News · Bispecific Antibody
285 stories
Sep 2, 26Stripped of AstraZeneca safety net, BMS could face ‘carnage’ if high-risk clinical trial fails
Aug 20, 26Why Pheast’s CEO has no regrets about transparent approach to R&D despite competitors circling
285 stories